Inventor
Robert H. Getzenberg
Inventor
Pittsburgh, PA, US
Overview
Patents· 16 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Kprimary
C07KPeptides27%
G01NInvestigating or analysing materials by determining their chemical or physical properties24%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations16%
A61KPreparations for medical, dental or toiletry purposes12%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests10%
C07CAcyclic or carbocyclic compounds2%
C07DHeterocyclic compounds2%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms2%
G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biology2%
Y02ATechnologies for adaptation to climate change2%
PatentTitleYear
9,624,161'Estrogen receptor ligands and methods of use thereof'20177,838,251'Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof'20107,598,042'Early prostate cancer antigens (EPCA), polynucleotide sequences encoding them, and their use'20097,531,634'Bladder matrix protein peptides and methods of detection of bladder cancer'20097,321,830'Identifying drugs for and diagnosis of benign prostatic hyperplasia using gene expression profiles'20087,258,991'Antibody to bladder cancer nuclear matrix protein and its use'20077,189,823'Antibody against illfdyfnr'20076,951,926'Antibody to bladder cancer nuclear matrix protein and its use'20056,617,432'Nuclear matrix proteins polynucleotide sequences encoding them and their use'20036,280,956'Antibodies to bladder cancer nuclear matrix proteins and their use'20016,232,443'Renal nuclear matrix proteins, polynucleotide sequences encoding them, and their use'20016,030,793'Nuclear matrix proteins'20005,874,539'Antibodies to nuclear matrix proteins'19995,866,535'Bladder nuclear matrix proteins, polynucleotide sequences encoding them, and their use'19995,849,509'Nuclear matrix proteins'19985,824,490'Method for detecting prostate cancer using a reagent which binds prostate cancer-1 protein'1998Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1998–1999Patents assigned to UNIV JOHNS HOPKINS MED (3)· patent assignee history
1998–2010Based in Pittsburgh, PA, US· patent location history
1998–2000Based in Branford, CT, US· patent location history
1999–2010Patents assigned to UNIV PITTSBURGH (11)· patent assignee history
2000Patents assigned to UNIV JOHNS HOPKINS (1)· patent assignee history
2007–2009Based in Lutherville, MD, US· patent location history
2008Patents assigned to GENE LOGIC INC (1)· patent assignee history
2017Patents assigned to GTX INC (1)· patent assignee history
2017Based in Memphis, TN, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| UNIV PITTSBURGH | 11 | 1999–2010 |
| UNIV JOHNS HOPKINS MED | 3 | 1998–1999 |
| GENE LOGIC INC | 1 | 2008 |
| GTX INC | 1 | 2017 |
| UNIV JOHNS HOPKINS | 1 | 2000 |
Locations
| Location | Patents | Span |
|---|---|---|
| Pittsburgh, Pennsylvania, US | 10 | 1998–2010 |
| Branford, CT, US | 3 | 1998–2000 |
| Lutherville, Maryland, US | 2 | 2007–2009 |
| Memphis, TN, US | 1 | 2017 |